NINDS encourages applications that apply nanoscience and nanotechnology approaches to address problems in biology and medicine. This announcement is made together with 16 other NIH components and is supported by 2 funding mechanisms: R01 and R21.
Nanoscience and nanotechnology refer to the understanding and control of matter at the atomic, molecular, or macromolecular levels—at the length scale of approximately 1 - 100 nanometers. This announcement encourages the study of basic biological phenomena and engineer nanotechnology solutions that will enable biomedical breakthroughs in the diagnosis, treatment, and management of diseases and traumatic injuries. Projects may include the development, modification, or integration of advanced nanotechnologies and nanoscience-based tools, methods, concepts, and devices; and engineering nanoscale structures and systems to study and understand biological processes in health and disease, and to develop novel diagnostics and interventions for treating disease.
Potential applicants should contact Stephanie Fertig, research project manager, Office of Translational Research, NINDS, at 301-496-1779 or email@example.com. For more information visit http://grants.nih.gov/grants/guide/pa-files/PA-11-148.html or http://grants.nih.gov/grants/guide/pa-files/PA-11-149.html.